[Federal Register Volume 65, Number 184 (Thursday, September 21, 2000)]
[Notices]
[Pages 57189-57190]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-24232]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


White House Commission on Complementary and Alternative Medicine 
Policy; Notice of Meeting

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is given of a meeting of the 
White House Commission on Complementary and Alternative Medicine 
Policy. The purpose of the meeting is to convene the Commission for a 
public hearing on coordinated Research and Development activities 
relating to complementary and alternative medicine practices and 
products, and to receive public testimony from individuals and 
organizations interested in the subject of federal policy regarding 
complementary and alternative medicine. Comments received at the 
meeting may be used by the Commission to prepare the Report to the 
President as required by the Executive Order.
    Comments should focus on Coordinated Research and Development 
Activities To Increase Knowledge of Complementary and Alternative 
Medicine Practices and Interventions. Issues to be discussed include 
the following: Research Priorities and Public Input; Federal, Private 
Sector, and Not-for-Profit Sector Support for CAM Research; 
Facilitating CAM Research and Regulatory Challenges; Practice-based 
Research and Outcomes Research. Discussion also may focus on the 
following questions:
    (1) What can be done to expand the current research environment so 
that practices and interventions that lie outside conventional science 
are adequately and appropriately addressed?
    (2) What types of incentives are needed to stimulate the research 
of CAM practices and interventions by the public and private sectors?
    (3) How can we more effectively integrate the CAM and conventional 
research communities to stimulate and coordinate research?
    Some Commission members may participate by telephone conference. 
The meeting is open to the public and opportunities for oral statements 
by the public will be provided on October 5, from about 1:15 p.m.-2:15 
p.m.; and on October 6, from about 2:40 p.m.-3:40 p.m. (approximate 
times).
    Name of Committee: White House Commission on Complementary and 
Alternative Medicine Policy.
    Date: October 5-6, 2000.
    Time: October 5-8:30 a.m.-5:30 p.m.; October 6-8:30 a.m.-4 p.m.

[[Page 57190]]

    Place: Hubert H. Humphrey Building, Room 800, 200 Independence 
Avenue, S.W., Washington, DC 20201.
    Contact Persons: Michele M. Chang, CMT, MPH, Executive Secretary OR 
Stephen C. Groft, Pharm. D., Executive Director, 6701 Rockledge Drive, 
Room 1010, MSC 7707, Bethesda, MD 20817-7707, Phone: (301) 435-7592, 
Fax: (301) 480-1691, E-mail: [email protected].
    Because of the need to obtain the views of the public on these 
issues as soon as possible and because of the early deadline for the 
report required of the Commission, this notice is being provided at the 
earliest possible time.

SUPPLEMENTARY INFORMATION: The President established the White House 
Commission on Complementary and Alternative Medicine Policy on March 7, 
2000 by Executive Order 13147. The mission of the White House 
Commission on Complementary and Alternative Medicine Policy is to 
provide a report, through the Secretary of the Department of Health and 
Human Services, on legislative and administrative recommendations for 
assuring that public policy maximizes the benefits of complementary and 
alternative medicine to Americans.

Public Participation

    The meeting is open to the public with attendance limited by the 
availability of space on a first come, first serve basis. Members of 
the public who wish to present oral comments may register by calling 1-
800-953-3298 or by accessing https://safe2.sba.com/whccamp/index.cfm no 
later than September 29, 2000.
    Oral comments will be limited to five minutes. Individuals who 
register to speak will be assigned in the order in which they 
registered. Due to time constraints, only one representative from each 
organization will be allotted time for oral testimony. The number of 
speakers and the time allotted may also be limited by the number of 
registrants. All requests to register should include the name, address, 
telephone number, and business or professional affiliation of the 
interested party, and should indicate the area of interest or question 
(as described above) to be addressed.
    Any person attending the meeting who has not registered to speak in 
advance of the meeting will be allowed to make a brief oral statement 
during the time set aside for public comment if time permits, and at 
the chairperson's discretion. Individuals unable to attend the meeting, 
or any interested parties, may send written comments by mail, fax, or 
electronically to the staff office of the Commission for inclusion in 
the public record.
    When mailing or faxing written comments provide, if possible, an 
electronic version on diskette. Persons needing special assistance, 
such as sign language interpretation or other special accommodations, 
should contact the Commission staff at the address or telephone number 
listed no later than September 29, 2000.

    Dated: September 12, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committe Policy.
[FR Doc. 00-24232 Filed 9-20-00; 8:45 am]
BILLING CODE 4140-01-M